Navigation Links
Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial Hypertension
Date:8/25/2010

e registry to PROSPECTively evaluate use of VELETRI in patients with PAH, is a multicenter, observational, U.S.-based registry, which is currently ongoing.

About Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of an affected individual.  The function of the heart and lungs is severely compromised, manifested by a limited exercise capacity, and, ultimately, a reduced life expectancy.  Approximately 100,000 people in Europe and the United States are afflicted with either primary or secondary forms of the disease related to conditions or tissue disorders that affect the lungs, such as scleroderma, lupus, HIV/AIDS or congenital heart disease.

PAH is associated with structural changes in both the pulmonary vasculature and the right ventricle.  Recent advances [1] in the understanding of the pathogenic factors leading to the pulmonary vascular disease have led to the development of new therapies targeting specific pathways (the prostacyclin pathway; the endothelin pathway; and the nitric oxide pathway) [2].  The available therapies have positive effects in PAH, but they do not provide a cure, and in many patients the disease will progress.  PAH remains a serious life-threatening condition [2,3]. Early recognition and an understanding of the selection and timing of therapeutic options remain critical elements in the optimal management of patients with this disorder.

References

  1. Farber HW; Loscalzo J. Mechanisms of disease: pulmonary arterial hypertension. N. Eng. J. Med. 2004; 351:1655-65.
  2. Humbert M; Sitbon O; Simonneau G. Treatment of pulmonary arterial hypertension. N. Eng. J. Med. 2004; 351:1425-36.
  3. Humbert M; Morrell NW; Archer SL; et al. Cellular and molecular pathobiology of pulmona
    '/>"/>

SOURCE Actelion Pharmaceuticals US, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. China Yongxin Pharmaceuticals Reports Second Quarter 2010 Results
2. Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) in Fibromyalgia
3. Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application
4. Shareholder Class Action Filed Against SciClone Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
5. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
6. Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human
7. Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million
8. Trubion Pharmaceuticals Inc. Reports Second-Quarter and First-Half 2010 Financial Results
9. Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
10. Ferring Pharmaceuticals FIRMAGON® Joins Race to End Prostate Cancer as Official Sponsor of the Great Prostate Cancer Challenge / Dash for Dad
11. Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015 Hitachi Medical Systems ... OASIS *    at ECR 2015 - the ... set a benchmark for patient-centric care. The new features ... whilst optimizing workflow management and costs. OASIS demonstrates the ... for imaging in Neurology, Orthopaedics, Paediatrics, Oncology, Vascular and ...
(Date:3/5/2015)... Calif. , March 5, 2015  Asterias Biotherapeutics, ... the emerging field of regenerative medicine, announced today that ... the nation,s top rehabilitation hospitals for spinal cord injury ... 1/2a clinical trial of AST-OPC1 (oligodendrocyte progenitor cells) in ... spinal cord injury (SCI). The Phase ...
(Date:3/5/2015)... Denmark , March 5, 2015 ... that applies its innovative TransCon technology to address ... present two posters at the ENDO 2015 conference ... The posters will be presented on Thursday, March ... is being held from 1:00pm-3:00pm PST, and are ...
Breaking Medicine Technology:Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4Ascendis Pharma to Present at ENDO 2015 2
(Date:3/5/2015)... Rosa, CA (PRWEB) March 05, 2015 SuperCloset ... a SuperPro! The series aims to teach viewers everything ... garden with hydroponics. Grow Like a SuperPro takes you from ... between. From how to clone, to how to prune Grow ... growing. They are offering the whole series for download for ...
(Date:3/5/2015)... At the 7th Annual Mississippi Addiction ... treatment met today in Jackson, Mississippi to listen to ... the numerous respected speakers will be William S. ... that pain medications have had in today’s opiate overdose ... "It is hard to believe that much of the ...
(Date:3/5/2015)... Califia Farms , the fastest-growing natural ... coffee drinks category[1], today unveils its new Concentrated Cold ... Calif. Concentrated Cold Brew (CCB) is the centerpiece ... the next wave of the coffee-taste evolution by giving ... their own baristas. , Califia Farms CCB has ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Supply & ... annual listing of “Pros to Know” in the supply ... two members of MEBC’s leadership team were included on ... nominated and received this award due to their hard ... innovative methods for meeting and resolving client needs and ...
(Date:3/5/2015)... Minneapolis, Minn. (PRWEB) March 05, 2015 ... authority, invites healthcare organizations to participate in its ... includes data from executive and director-level positions, and ... , Last year’s report featured data on ... 28 independent children’s healthcare organizations and 7 subsidiary ...
Breaking Medicine News(10 mins):Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2
... and skulls of trout causing them to swim in circles till ... disease is referred to as ‘whirling disease’. // ... 80,000 of the fresh water fish. ,The parasite, Myxobolus ... North Branch, which are several miles from both hatcheries. It is ...
... or more hours per week of strenuous recreational activity ... 23 percent. According to a survey conducted on 15,000 ... protective effect against invasive breast cancer throughout a woman’s ... for most women physical activity may reduce the risk ...
... regulator that triggers growth of stem cells during brain ... of the lethal brain cancer malignant glioma. //In experiments ... out the function of a particular regulatory protein, Olig2, ... their findings suggest that targeting Olig2 could offer a ...
... of keeping everything from happening at once' ,?????……….Anon ... controls the physiological processes of all living beings. ... of our cells there is a remarkable clock that is ... our body functions in accordance to a rhythm that traces ...
... faculty members published in PLoS ONE, the international, peer-reviewed, ... (PLoS). Drs. Amin A. Muhammad Gadit and Gerry Mugford ... depression among house holds in three capital cities of ... ,Dr. Muhammad Gadit explained that Pakistan, among the ...
... Food and Drug Administration, FDA, warns consumers to ... medications over the Internet.// ,The drugs ... in reality a powerful anti-psychotic, which would eventually ... officials revealed that Ambien-a sleep aid, Xanax and ...
Cached Medicine News:Health News:Active Lifestyle Reduces Risk of Invasive Breast Cancer 2Health News:'Gateway' Gene Discovered for Brain Cancer 2Health News:Rhythms of Life 2Health News:Rhythms of Life 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: